Haleli Sharir

1.5k total citations
17 papers, 1.2k citations indexed

About

Haleli Sharir is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Haleli Sharir has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Pharmacology. Recurrent topics in Haleli Sharir's work include Receptor Mechanisms and Signaling (8 papers), Cannabis and Cannabinoid Research (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Haleli Sharir is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Cannabis and Cannabinoid Research (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Haleli Sharir collaborates with scholars based in United States, Israel and Netherlands. Haleli Sharir's co-authors include Mary E. Abood, Michal Hershfinkel, Ankur Kapur, Marc G. Caron, Larry S. Barak, Yushi Bai, Pingwei Zhao, Linda Console‐Bram, G. Cristina Brailoiu and Eugen Brailoiu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Biochemistry.

In The Last Decade

Haleli Sharir

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haleli Sharir United States	14	641	514	419	213	165	17	1.2k
Zhao-Hui Song United States	24	929 1.4×	529 1.0×	590 1.4×	180 0.8×	45 0.3×	54	1.4k
Carmen Navarrete Spain	21	720 1.1×	322 0.6×	293 0.7×	101 0.5×	49 0.3×	33	1.2k
Erik Ryberg Sweden	12	1.5k 2.3×	422 0.8×	725 1.7×	366 1.7×	82 0.5×	15	1.9k
Clara Andradas Spain	13	678 1.1×	324 0.6×	273 0.7×	224 1.1×	38 0.2×	16	972
María Gómez‐Cañas Spain	18	801 1.2×	277 0.5×	367 0.9×	98 0.5×	42 0.3×	33	1.1k
Juha R. Savinainen Finland	23	1.2k 1.9×	604 1.2×	559 1.3×	318 1.5×	23 0.1×	56	1.8k
Ana M. Martín‐Moreno Spain	12	638 1.0×	383 0.7×	418 1.0×	53 0.2×	41 0.2×	12	1.3k
М. Yu. Bobrov Russia	12	545 0.9×	186 0.4×	325 0.8×	81 0.4×	51 0.3×	52	861
Yang Chang United States	5	199 0.3×	513 1.0×	236 0.6×	116 0.5×	66 0.4×	8	1.5k
Feng‐Shiun Shie Taiwan	25	219 0.3×	569 1.1×	320 0.8×	153 0.7×	99 0.6×	42	1.8k

Countries citing papers authored by Haleli Sharir

Since Specialization

Citations

This map shows the geographic impact of Haleli Sharir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haleli Sharir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haleli Sharir more than expected).

Fields of papers citing papers by Haleli Sharir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haleli Sharir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haleli Sharir. The network helps show where Haleli Sharir may publish in the future.

Co-authorship network of co-authors of Haleli Sharir

This figure shows the co-authorship network connecting the top 25 collaborators of Haleli Sharir. A scholar is included among the top collaborators of Haleli Sharir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haleli Sharir. Haleli Sharir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Snitser, Olga, Haleli Sharir, Noga Kozer, et al.. (2020). Ubiquitous selection for mecA in community-associated MRSA across diverse chemical environments. Nature Communications. 11(1). 6038–6038. 21 indexed citations

Bassoni, Daniel L., András Szabó, Haleli Sharir, et al.. (2018). A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors. Assay and Drug Development Technologies. 16(7). 384–396. 3 indexed citations

Siddiquee, Khandaker, Haleli Sharir, Feng Qi, et al.. (2017). A Systematic Approach to Identify Biased Agonists of the Apelin Receptor through High-Throughput Screening. SLAS DISCOVERY. 22(7). 867–878. 11 indexed citations

Console‐Bram, Linda, Thomas F. Gamage, Haleli Sharir, et al.. (2016). Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones. Bioorganic & Medicinal Chemistry Letters. 26(7). 1827–1830. 5 indexed citations

Zhao, Pingwei, et al.. (2016). Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor. Biochemistry. 56(3). 473–486. 21 indexed citations

Console‐Bram, Linda, Eugen Brailoiu, G. Cristina Brailoiu, Haleli Sharir, & Mary E. Abood. (2014). Activation of GPR18 by cannabinoid compounds: a tale of biased agonism. British Journal of Pharmacology. 171(16). 3908–3917. 134 indexed citations

Hurst, Dow P., Derek M. Shore, Simone Bertini, et al.. (2014). CB2-Selective Cannabinoid Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides. Journal of Medicinal Chemistry. 57(21). 8777–8791. 48 indexed citations

Kotsikorou, Evangelia, Haleli Sharir, Derek M. Shore, et al.. (2013). Identification of the GPR55 Antagonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands. Biochemistry. 52(52). 9456–9469. 69 indexed citations

Sharir, Haleli, Linda Console‐Bram, Christina Mundy, et al.. (2012). The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55. Journal of Neuroimmune Pharmacology. 7(4). 856–865. 72 indexed citations

10.

Kotsikorou, Evangelia, Dow P. Hurst, Haleli Sharir, et al.. (2011). Identification of the GPR55 Agonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands. Biochemistry. 50(25). 5633–5647. 62 indexed citations

11.

Heynen‐Genel, Susanne, Russell Dahl, Shenghua Shi, et al.. (2011). Screening for Selective Ligands for GPR55 - Antagonists. Europe PMC (PubMed Central). 23 indexed citations

12.

Sharir, Haleli, et al.. (2010). Zinc Released from Injured Cells Is Acting via the Zn2+-sensing Receptor, ZnR, to Trigger Signaling Leading to Epithelial Repair. Journal of Biological Chemistry. 285(34). 26097–26106. 92 indexed citations

13.

Sharir, Haleli & Mary E. Abood. (2010). Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacology & Therapeutics. 126(3). 301–313. 183 indexed citations

14.

Zhao, Pingwei, Haleli Sharir, Ankur Kapur, et al.. (2010). Targeting of the Orphan Receptor GPR35 by Pamoic Acid: A Potent Activator of Extracellular Signal-Regulated Kinase and β-Arrestin2 with Antinociceptive Activity. Molecular Pharmacology. 78(4). 560–568. 120 indexed citations

15.

Kapur, Ankur, Pingwei Zhao, Haleli Sharir, et al.. (2009). Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands. Journal of Biological Chemistry. 284(43). 29817–29827. 224 indexed citations

16.

Sharir, Haleli & Michal Hershfinkel. (2005). The extracellular zinc-sensing receptor mediates intercellular communication by inducing ATP release. Biochemical and Biophysical Research Communications. 332(3). 845–852. 28 indexed citations

17.

Sharir, Haleli, et al.. (2004). Extracellular Zinc Triggers ERK-dependent Activation of Na+/H+ Exchange in Colonocytes Mediated by the Zinc-sensing Receptor. Journal of Biological Chemistry. 279(50). 51804–51816. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact